Skip to content
Trial Eligibility
Menu

Lung Cancer Clinical Trials near Baltimore, MD

244 studies for Lung Cancer are recruiting at 460 sites within 50 miles of Baltimore, Maryland, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Lung Cancer trials in the US or all trials near Baltimore.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Lung Cancer studies enrolling near Baltimore

Showing the 50 nearest of 244 studies.
  1. Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

    NCT04267848

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Johns Hopkins University/Sidney Kimmel Cancer Center (Baltimore, MD); Kaiser Permanente-Woodlawn Medical Center (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    19 sites within 50 mi
  2. Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

    NCT03851445

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Kaiser Permanente-Woodlawn Medical Center (Baltimore, MD); Saint Agnes Hospital (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    18 sites within 50 mi
  3. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    NCT05334069

    • Observational
    • Ages 40 to 75 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest sites: MedStar Franklin Square Medical Center/Weinberg Cancer Institute (Baltimore, MD); Mercy Medical Center (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    13 sites within 50 mi
  4. Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

    NCT06616584

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Kaiser Permanente-Woodlawn Medical Center (Baltimore, MD); Saint Agnes Hospital (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    11 sites within 50 mi
  5. Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

    NCT05642572

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Kaiser Permanente-Woodlawn Medical Center (Baltimore, MD); Kaiser Permanente Lutherville - Timonium Medical Center (Lutherville, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    9 sites within 50 mi
  6. Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

    NCT06031688

    • Phase 2
    • Ages 18 Minutes and older
    • Sex: All

    Nearest sites: Kaiser Permanente-Woodlawn Medical Center (Baltimore, MD); Kaiser Permanente Lutherville - Timonium Medical Center (Lutherville, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    9 sites within 50 mi
  7. Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

    NCT06418204

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Sinai Hospital of Baltimore (Baltimore, MD); University of Maryland/Greenebaum Cancer Center (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    8 sites within 50 mi
  8. Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

    NCT05624996

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Greater Baltimore Medical Center (Baltimore, MD); Sinai Hospital of Baltimore (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  9. GEMINI-NSCLC: NSCLC Biomarker Study

    NCT05236114

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Johns Hopkins University (Baltimore, MD); University of Maryland (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  10. Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

    NCT06500481

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Johns Hopkins University/Sidney Kimmel Cancer Center (Baltimore, MD); Sibley Memorial Hospital (Washington D.C., DC)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  11. A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

    NCT06667076

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: University of Maryland (Baltimore, MD); Maryland Oncology Hematology P A (Silver Spring, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  12. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    NCT03452774

    • Observational
    • Ages Any age
    • Sex: All

    Nearest sites: Massive Bio SYNERGY-AI site (Baltimore, MD); Massive Bio SYNERGY-AI site (Towson, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  13. Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer

    NCT04499053

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Harry and Jeannette Weinberg Cancer Institute at Franklin Square (Baltimore, MD); Marlene and Stewart Greenebaum Comprehensive Cancer Center (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  14. Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

    NCT06096844

    • Phase 3
    • Ages 70 years and older
    • Sex: All

    Nearest sites: Sinai Hospital of Baltimore (Baltimore, MD); University of Maryland/Greenebaum Cancer Center (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  15. A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

    NCT06119581

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Johns Hopkins Bayview Medical Center (Baltimore, MD); USO - Maryland Oncology Hematology (Columbia, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  16. Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC

    NCT06745882

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Johns Hopkins Sidney Kimmel Comprehensive Cancer Center (Baltimore, MD); Medstar Franklin Square (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  17. A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer

    NCT06800339

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Maryland Proton Treatment Center (Baltimore, MD); University of Maryland Greenebaum Cancer Center (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  18. Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

    NCT05098132

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: University of Maryland (Baltimore, MD); Georgetown University (Washington D.C., DC)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  19. A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

    NCT05498428

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Sidney Kimmel Cancer Center - Bayview Campus (Baltimore, MD); Johns Hopkins Office of Capital Region Research - Sibley Memorial Hospital (Washington D.C., DC)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  20. A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

    NCT06095505

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: University of Maryland Greenebaum Comprehensive Cancer Center (Baltimore, MD); Georgetown Lombardi Cancer Center (Washington D.C., DC)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  21. Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

    NCT06287775

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Johns Hopkins University/Sidney Kimmel Cancer Center (Baltimore, MD); University of Maryland/Greenebaum Cancer Center (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  22. A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

    NCT06627647

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Research Site (Baltimore, MD); Research Site (York, PA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  23. Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

    NCT06890598

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Johns Hopkins Bayview Medical Center (Baltimore, MD); University of Maryland (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  24. Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

    NCT07291037

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Research Site (Baltimore, MD); Research Site (Brandywine, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  25. Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

    NCT04613596

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: The Sidney Kimmel Comprehensive Cancer Center (Baltimore, MD); USOR - Virginia Cancer Specialists - Fairfax Office (Fairfax, VA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  26. Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC

    NCT04686305

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Research Site (Baltimore, MD); Research Site (Fairfax, VA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  27. Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

    NCT05061550

    • Phase 2
    • Ages 18 to 95 years
    • Sex: All

    Nearest sites: Research Site (Baltimore, MD); Research Site (Fairfax, VA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  28. Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer

    NCT05142189

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Johns Hopkins Sidney Kimmel Comprehensive Cancer Center (Baltimore, MD); NEXT Virginia (Fairfax, VA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  29. Tempus Small Cell Lung Cancer Observational Study (Sculptor)

    NCT05257551

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Johns Hopkins University (Baltimore, MD); Cancer Care Association of York (York, PA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  30. Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

    NCT05379985

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Johns Hopkins University (Baltimore, MD); Next Oncology Virginia (Fairfax, VA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  31. A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

    NCT05652686

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Sidney Kimmel Comprehensive Cancer Center at John Hopkins (Baltimore, MD); NEXT Virginia (Fairfax, VA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  32. Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

    NCT06040541

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Johns Hopkins University (Baltimore, MD); NEXT Oncology Virginia (Fairfax, VA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  33. A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

    NCT06203210

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: John Hopkins School of Medicine (Baltimore, MD); University of Maryland Greenebaum Comprehensive Cancer Center (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  34. Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

    NCT06343402

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: University of Maryland Marlene & Stewart Greenebaum Comprehensive Cancer Center (Baltimore, MD); NEXT Oncology (Fairfax, VA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  35. Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

    NCT06472245

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Ascension Saint Agnes Hospital (Baltimore, MD); Georgetown Lombardi Comprehensive Cancer Center (Washington D.C., DC)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  36. Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

    NCT06767514

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Clinical Study Site (Baltimore, MD); Clinical Study Site (Fairfax, VA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  37. Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)

    NCT06780098

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: MedStar Franklin Square Medical Center ( Site 0033) (Baltimore, MD); Virginia Cancer Specialists (VCS) ( Site 0408) (Fairfax, VA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  38. A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

    NCT06793215

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Saint Agnes Hospital - Baltimore - Hunt - PPDS (Baltimore, MD); Walter Reed National Military Medical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  39. Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

    NCT06881784

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Johns Hopkins University of Medicine (Baltimore, MD); Virginia Cancer Specialists (Fairfax, VA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  40. A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

    NCT07020221

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Johns Hopkins University (Baltimore, MD); Virginia Cancer Specialists (Fairfax, VA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  41. A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

    NCT07154290

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: University of Maryland Greenebaum Comprehensive Cancer Center (Baltimore, MD); Georgetown University (Washington D.C., DC)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  42. A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies

    NCT07223047

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Johns Hopkins Hospital (Baltimore, MD); NEXT Virginia (Fairfax, VA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  43. Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

    NCT07349537

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Johns Hopkins (Baltimore, MD); NEXT - Virginia (Fairfax, VA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  44. Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

    NCT02984761

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest site: Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  45. Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers

    NCT04410796

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: John Hopkins Medical Center (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  46. Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

    NCT04777994

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Johns Hopkins Hospital /ID# 254056 (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  47. A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

    NCT05123482

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Research Site (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  48. Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer

    NCT05168566

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Maryland Medical Center (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  49. Full-Field Optical Coherence Tomography (FFOCT) for Evaluation of Bronchoscopic Small Biopsy Specimens

    NCT05171478

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: Johns Hopkins Hospital (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  50. Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

    NCT05176483

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Exelixis Clinical Site #14 (Baltimore, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Lung Cancer clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.